<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2025.12809</article-id>
<article-id pub-id-type="publisher-id">ETM-29-3-12809</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF‑C/VEGFR‑3 signaling pathway </article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Du</surname><given-names>Hai-Tao</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Ping</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>03</month>
<year>2025</year></pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>01</month>
<year>2025</year></pub-date>
<volume>29</volume>
<issue>3</issue>
<elocation-id>59</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2025 Du and Liu</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Exp Ther Med 12:<related-article id="RA1" related-article-type="retracted-article" vol="12" page="2120" ext-link-type="doi" xlink:href="10.3892/etm.2016.3601">2120&#x2013;2128</related-article>, 2016; DOI: 10.3892/etm.2016.3601</p>
<p>Following the publication of the above paper, a concerned reader drew to the Editor&#x2019;s attention that, regarding the immunofluorescence microscopic assay experiments shown in Fig. 4A-C on p. 2125, all three panels contained overlapping sections of data, such that data from the same original source had apparently been used in the panels of this figure to portray the results of supposedly differently performed experiments. In addition, there were identical sections of data shown for the immunohistochemical staining of corneal tissue in Fig. 1D on p. 2123, which were difficult to attribute purely to coincidence.</p>
<p>Following an internal enquiry, the Editor of <italic>Experimental and Therapeutic Medicine</italic> has been able to verify the claims made by the interested reader; therefore, in view of the abovementioned anomalies that were identified, and owing to an overall lack of confidence in the presented data, the Editor has decided that the paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership of the Journal for any inconvenience caused.</p>
</body>
</article>
